
|Articles|April 25, 2023
Discussing Challenges in mRNA Therapeutics with Phil Challis (INTERPHEX 2023)
Phil Challis, vice-president of product development at eTheRNA, discusses four of the major challenges in working with mRNA therapeutics.
Advertisement
Phil Challis, vice-president of product development at eTheRNA, discusses four of the major challenges in working with mRNA therapeutics. Some topics he touches on include; what makes a good RNA construct; making RNA more tolerable; storage and distribution of lipid nanoparticles; and more.
For more INTERPHEX 2023 video content, check
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
HanchorBio–WuXi Biologics Partnership Targets Fusion Protein Development Challenges
2
GSK’s Arexvy Gains EU Approval for Adults Aged 18 Years and Older
3
FDA Fast Tracks Innovent’s Trispecific Antibody for Multiple Myeloma
4
FDA Priority Review of Subcutaneous Lecanemab Signals Shift in Alzheimer’s Treatment Delivery
5




